Hao Bi

Dr. Hao Bi


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2020 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
HBHao Bi
Hao Bi
RYRu Yang
Ru Yang
CWChunchen Wu
Chunchen Wu
JXJianbo Xia
Jianbo Xia
While the majority of worldwide hepatitis E viral (HEV) infections that occur in people are from contaminated water or food sources, there has also been a steadily rising number of reported cases of transfusion-transmitted HEV (TT-HEV) in blood donation recipients. For most, HEV infection is acute, self-limiting and asymptomatic. However, patients that are immunocompromised, especially transplant patients, are at much higher risk for developing chronic infections, which can progress to cirrhosis and liver failure, along with overall increased mortality. Because of the rising trend of HEV serological prevalence among the global population, and the fact that TT-HEV infection can cause serious clinical consequences among those patients most at need for blood donation, the need for screening for TT-HEV has been gaining in prominence as an important public health concern for both developing and developed countries. In the review, we summarise evidence for and notable cases of TT-HEV infections, the various aspects of HEV screening protocols and recent trends in the implementation of TT-HEV broad-based blood screening programmes.

16 December 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
HBHao Bi
Hao Bi
YCYuting Chen
Yuting Chen
YWYihan Wu
Yihan Wu
ZSZuliang Shi
Zuliang Shi
JXJianbo Xia
Jianbo Xia
QYQiuyue Yan
Qiuyue Yan
Background: In this hospital-wide evaluation of point-of-care testing (POCT) glucose meters, we introduced a residual safety margin (r) anchored to ISO 15197:2013 thresholds to quantify tolerance, move beyond binary pass/fail assessments, and enable risk stratification. Methods: Thirty-five departmental glucose meters were compared with a central laboratory reference at five predefined glucose concentrations. Compliance was assessed using ISO 15197:2013 point-wise limits, Bland–Altman analysis was used to estimate bias and limits of agreement, and the mean absolute relative difference (MARD) and root mean square error (RMSE) were calculated to summarize overall error. At each concentration, r was calculated for every department, ranked, and classified into low, medium, or high risk using allowable error thresholds based on biological variation, specifically total allowable error (TEa), mapped to the ISO limits. Results: All departments met ISO criteria (100% compliance; 95% CI: 97.9–100%). Mean bias was −1.43 mg/dL, with limits of agreement from −15.6 to 12.8 mg/dL; MARD was 3.8% (95% CI: 3.4–4.3%), and RMSE was 7.4 mg/dL (95% CI: 6.6–8.2 mg/dL). Despite universal compliance, r-based analysis revealed concentration-related heterogeneity and highlighted borderline-performing departments that were overlooked by conventional metrics. Conclusions: By anchoring residual safety margins to ISO thresholds, the r framework shifts POCT glucose assessment from a binary pass/fail decision to a risk-stratified ranking approach, exposing latent performance variation and supporting targeted quality improvement at the hospital level.